HCPCS 2015

G0428 Collagen meniscus implant procedure for filling meniscal defects (e.g. cmi, collagen scaffold, menaflex)
G0429 Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g. as a result of highly active antiretroviral therapy)
G0431 Drug screen, qualitative; multiple drug classes by high complexity test method (e.g. immunoassay, enzyme assay), per patient encounter
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening
G0434 Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter
G0435 Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening
G0436 Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes
G0437 Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
G0442 Annual alcohol misuse screening, 15 minutes
G0443 Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes
G0444 Annual depression screening, 15 minutes
G0445 High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes
G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes
G0447 Face-to-face behavioral counseling for obesity, 15 minutes
G0448 Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing
G0450 Screening for sexually transmitted infections, including laboratory tests for chlamydia, gonorrhea, syphilis and Hepatitis B
G0451 Development testing, with interpretation and report, per standardized instrument form
G0452 Molecular pathology procedure; physician interpretation and report
G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)
G0454 Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist
G0455 Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen
G0458 Low dose rate (ldr) prostate brachytherapy services, composite rate
G0459 Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy
G0463 Hospital outpatient clinic visit for assessment and management of a patient
G0464 Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)
G0466 A medically-necessary, face to face encounter( one- on- one) between a new patient and a FQHC practitioner during which time one or more FQHC services are rendered and includes a typical bundle of Medicare-covered services that would be furnished per diem to a patient receiving a FQHC visit.
G0467 A medically-necessary, face to face encounter( one- on- one) between an established patient and a FQHC practitioner during which time one or more FQHC services are rendered and includes a typical bundle of Medicare-covered services that would be furnished per diem to a patient receiving a FQHC visit.
G0468 A FQHC visit that includes an Initial Preventive Physical Examination (IPPE) or Annual Wellness Visit (AWV) and includes a typical bundle of Medicare-covered services that would be furnished per diem to a patient receiving an IPPE or AWV
G0469 A medically-necessary, face-to-face mental health encounter(one-on-one) between a new patient and a FQHC practitioner during which time one or more FQHC services are rendered and includes a typical bundle of Medicare covered services that would be furnished per diem to a patient receiving a mental health visit.
G0470 A medically-necessary, face-to-face mental health encounter(one-on-one) between an established patient and a FQHC practitioner during which time one or more FQHC services are rendered and includes a typical bundle of Medicare covered services that would be furnished per diem to a patient receiving a mental health visit.
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (SNF) or by a laboratory on behalf of a home health agency (HHA)
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
G0473 Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes
G0913 Improvement in visual function achieved within 90 days following cataract surgery
G0914 Patient care survey was not completed by patient
G0915 Improvement in visual function not achieved within 90 days following cataract surgery
G0916 Satisfaction with care achieved within 90 days following cataract surgery
G0917 Patient satisfaction survey was not completed by patient
G0918 Satisfaction with care not achieved within 90 days following cataract surgery
G3001 Administration and supply of tositumomab, 450 mg
G6001 Ultrasonic guidance for placement of radiation therapy fields
G6002 Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy
G6003 Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: up to 5mev
G6004 Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 6-10mev
G6005 Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 11-19mev
G6006 Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 20mev or greater
G6007 Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5mev
G6008 Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10mev
G6009 Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19mev
G6010 Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater
G6011 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5mev
G6012 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10mev
G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19mev
G6014 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20mev or greater
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
G6016 Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session
G6017 Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment
G6018 Ileoscopy,through stoma; with transendoscopic stent placement (includes predilation)
G6019 Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique
G6020 Colonoscopy through stoma; with transendoscopic stent placement (includes predilation)
G6021 Unlisted procedure, intestine
G6022 Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique
G6023 Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)
G6024 Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare tehnique
G6025 Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)
G6027 Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed
G6028 Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)
G6030 Amitriptyline
G6031 Benzodiazepines
G6032 Desipramine
G6034 Doxepin
G6035 Gold
G6036 Assay of imipramine
G6037 Nortriptyline
G6038 Salicylate
G6039 Acetaminophen
G6040 Alcohol (ethanol); any specimen except breath
G6041 Alkaloids, urine, quantitative
G6042 Amphetamine or methamphetamine
G6043 Barbiturates, not elsewhere specified
G6044 Cocaine or metabolite
G6045 Dihydrocodeinone
G6046 Dihydromorphinone
G6047 Dihydrotestosterone
G6048 Dimethadione
G6049 Epiandrosterone
G6050 Ethchlorvynol
G6051 Flurazepam
G6052 Meprobamate
G6053 Methadone
G6054 Methsuximide
G6055 Nicotine
G6056 Opiate(s), drug and metabolites, each procedure
G6057 Phenothiazine
G6058 Drug confirmation, each procedure
G8923 Left ventricular ejection fraction (lvef) < 40% or documentation of moderately or severely depressed left ventricular systolic function
G8924 Spirometry test results demonstrate fev1/fvc < 60% and patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)
G8925 Spirometry test results demonstrate fev1/fvc >=60% or patient does not have copd symptoms
G8926 Spirometry test not performed or documented, reason not given
G8927 Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer
G8928 Adjuvant chemotherapy not prescribed or previously received, reason given
G8929 Adjuvant chemotherapy not prescribed or previously received, reason not given
G8934 Left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function
G8935 Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
G8936 Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons) or (eg, lack of drug availability, other reasons attributable to the health care system)
G8937 Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given
G8938 Bmi is calculated, but patient not eligible for follow-up plan
G8939 Pain assessment documented, follow-up plan not documented, patient not eligible/appropriate
G8940 Screening for clinical depression documented, follow-up plan not documented, patient not eligible/appropriate
G8941 Elder maltreatment screen documented, patient not eligible for follow-up
G8942 Documented functional outcomes assessment and care plan within the previous 30 days
G8944 Ajcc melanoma cancer stage 0 through iic melanoma
G8946 Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g. high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular carcinoma in situ, atypical columnar hyperplasica, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells)
G8947 One or more neuropsychiatric symptoms
G8948 No neuropsychiatric symptoms
G8950 Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up documented
G8951 Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, patient not eligible/not appropriate
G8952 Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given
G8953 All quality actions for the applicable measures in the oncology measures group have been performed for this patient
G8955 Most recent assessment of adequacy of volume management
G8956 Patient receiving maintenance hemodialysis in an outpatient dialysis facility
G8958 Assessment of adequacy of volume management not documented, reason not given
G8959 Clinician treating major depressive disorder communicates to clinician treating comorbid condition
G8960 Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given
G8961 Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery
G8962 Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery
G8963 Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years
G8964 Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.G. , symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)
G8965 Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment
G8966 Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment
G8967 Warfarin or another oral anticoagulant that is fda approved prescribed
G8968 Documentation of medical reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved for the prevention of thromboembolism [eg, patients with mitral stenosis or prosthetic heart valves, patients with transient or reversible causes of af (eg, pneumonia, hyperthyroidism, pregnancy, cardiac surgery), allergy, risk of bleeding, other medical reasons]
G8969 Documentation of patient reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved (e.g. economic, social, and/or religious impediments, noncompliance or patient refusal, other patient reasons)
G0168-G0177 Wound Closure
G8970 No risk factors or one moderate risk factor for thromboembolism
G0173-G0177 Stereotactic Radiosurgery
G8971 Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
G0175-G0177 Team Conference
G8972 One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism
G0179-G0182 Physician Services
G0333-G0340 Pharmacy Fees
G8973 Most recent hemoglobin (hgb) level < 10 g/dl
G8974 Hemoglobin level measurement not documented, reason not given
G0281-G0283 Electrical Stimulation
G0337-E8002 Hospice
G8975 Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g. patients who have non-renal etiologies of anemia [e.g. sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)
G0288-G0289 Angiography and Arthroscopy
G8976 Most recent hemoglobin (hgb) level >= 10 g/dl
G8977 I intend to report the oncology measures group
Transcatheter Placement
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals
G0120-G0122 Screening Service, Colorectal, Other
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G8006-G9139 Physician Quality Reporting Indicator Code
G9140-L4631 CMS Demonstration Project
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting
G8981 Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals
H1N1 Administration and Vaccine
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G0248-G0250 Demonstration, INR
G0257-G0260 Emergency Dialysis
G8983 Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals
G0259-G0260 Arthrography Injection
G8985 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals
G0268-G0271 Cerumen Removal
G0269-G0271 Placement of Occlusive Device
G8986 Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting
G0270-G0271 Nutrition Therapy
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals
G0275-G0278 Angiography
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G8989 Self care functional limitation, discharge status, at discharge from therapy or to end reporting
G0364-G0372 Bone Marrow Aspiration
G8990 Other physical or occupational primary functional limitation, current status, at therapy episode outset and at reporting intervals
G0365-G0372 Vessel Mapping
G8991 Other physical or occupational primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G0378-G0384 Hospital Services
G0389-G0397 Ultrasound Scan for AAA
G8992 Other physical or occupational primary functional limitation, discharge status, at discharge from therapy or to end reporting
G0202-G0206 Mammography
G8993 Other physical or occupational subsequent functional limitation, current status, at therapy episode outset and at reporting intervals
G8994 Other physical or occupational subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G0390-G0397 Trauma Response Services
G8995 Other physical or occupational subsequent functional limitation, discharge status, at discharge from therapy or to end reporting
G0219-G0235 PET Imaging
G0398-G0400 Substance Abuse Assessment and Intervention
G8996 Swallowing functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
G8997 Swallowing functional limitation, projected goal status, at initial therapy treatment/outset and at discharge from therapy
G0402-G0405 Home Sleep Study Test
G8998 Swallowing functional limitation, discharge status, at discharge from therapy/end of reporting on limitation
G0252-G0260 Additional PET Imaging
G8999 Motor speech functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
G0403-G0405 Preventive Examination
G9143 Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)
G0406-G0408 Electrocardiogram
G0409-G0411 Telehealth Followup
G9147 Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration
G9148 National committee for quality assurance - level i medical home
G0412-G0415 Psychological Services
G0416-G0419 Bone Treatment
G9149 National committee for quality assurance - level 2 medical home
G0245-G0246 Physician Services, Diabetic
G9150 National committee for quality assurance - level 3 medical home
G0341-G0343 Islet Cell Transplant
G9151 Mapcp demonstration - state provided services
G9152 Mapcp demonstration - community health teams
G0251-V2025 Stereotactic Radiosurgery
G0293-G0294 Non-covered Procedures
G9153 Mapcp demonstration - physician incentive pool
G0302-G0305 Pulmonary Surgery Services
G9156 Evaluation for wheelchair requiring face to face visit with physician
G9157 Transesophageal doppler use for cardiac monitoring
G0306-G0328 Laboratory Services
G9158 Motor speech functional limitation, discharge status at discharge from therapy/end of reporting on limitation
G0027-G0103 Semen Analysis
G0420-G0421 Surgical Pathology
G9159 Spoken language comprehension functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
G9160 Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G0329-G0340 Electromagnetic Therapy
G0422-G0424 Educational Services
G9161 Spoken language comprehension functional limitation, discharge status at discharge from therapy/end of reporting on limitation
G9162 Spoken language expression functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
G0339-G0340 Robotic Radiosurgery
G9163 Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
Telehealth Consultation
G9164 Spoken language expression functional limitation, discharge status at discharge from therapy/end of reporting on limitation
G0008-G0010 Vaccine Adminstration
G9165 Attention functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
G0255-G0260 Sensory Nerve Conduction Testing
G0176-G0177 Activity Therapy
G9166 Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G0237-G0239 Therapeutic Procedures
G9167 Attention functional limitation, discharge status at discharge from therapy/end of reporting on limitation
G0101-G0103 Cervical Screening
G9168 Memory functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
G0102-G0103 Screening Services, Prostate
G9169 Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G0104-G0106 Screening Services, Colorectal
G9170 Memory functional limitation, discharge status at discharge from therapy/end of reporting on limitation
G0108-G0109 Training Services, Diabetes
G9171 Voice functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
G9172 Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G0117-G0118 Screening Services, Glaucoma
G9173 Voice functional limitation, discharge status at discharge from therapy/end of reporting on limitation
G0425-G0427 Rehabilitation Services
G0247-G0250 Diabetic Foot Care
G9174 Other speech language pathology functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
G9175 Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G0186-G0206 Destruction
G0295-G0305 Electromagnetic Therapy
G9176 Other speech language pathology functional limitation, discharge status at discharge from therapy/end of reporting on limitation
G0123-G0124 Screening Services, Cytopathology
G9186 Motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
G0127-G0129 Nail Trimming
G9187 Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, fluid status, medication reconciliation/management, patient compliance with orders/plan of care, performance of activities of daily living, appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code
G0128-G0129 Services, Nursing and Occupational Therapy
G9188 Beta-blocker therapy not prescribed, reason not given
G9189 Beta-blocker therapy prescribed or currently being taken
G0130-G0148 SEXA Study
G0141-G0148 Screening Services, Cytopathology, Other
G9190 Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)
G9191 Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)
G0151-G0166 Allied Health Services
G9192 Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)
G9196 Documentation of medical reason(s) for not ordering first or second generation cephalosporin for antimicrobial prophylaxis
G9197 Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis
G9198 Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given
G9203 Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
G9204 Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
G9205 Patient starting antiviral treatmentfor hepatitis c during the measurement period
G9206 Patient starting antiviral treatment for hepatitis c during the measurement period
G9207 Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
G9208 Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
G9209 Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
G9210 Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)
G9211 Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given
G9212 Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
G9213 Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
G9217 Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given
G9219 Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient''s cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient''s cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)
G9222 Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3
G9223 Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%
G9225 Foot exam was not performed, reason not given
G9226 Foot examination performed (includes examination through visual inspection, sensory exam with monofilament, and pulse exam - report when all of the 3 components are completed)
G9227 Functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan
G9228 Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)
G9229 Chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)
G9230 Chlamydia, gonorrhea, and syphilis not screened, reason not given
G9231 Documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy
G9232 Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason
G9233 All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient
G9234 I intend to report the total knee replacement measures group
G9235 All quality actions for the applicable measures in the general surgery measures group have been performed for this patient
G9236 All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient
G9237 I intend to report the general surgery measures group
G9238 I intend to report the optimizing patient exposure to ionizing radiation measures group
G9239 Documentation of reasons for patient initiaiting maintenance hemodialysis with a catheter as the mode of vascular access (eg, patient has a maturing avf/avg, time-limited trial of hemodialysis, patients undergoing palliative dialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons)
G9240 Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated
G9241 Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated
G9242 Documentation of viral load equal to or greater than 200 copies/ml or viral load not performed
G9243 Documentation of viral load less than 200 copies/ml
G9244 Antiretroviral thereapy not prescribed
G9245 Antiretroviral therapy prescribed
G9246 Patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits
G9247 Patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits
G9250 Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment
G9251 Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment
G9254 Documentation of patient discharged to home later than post-operative day 2 following cas
G9255 Documentation of patient discharged to home no later than post operative day 2 following cas
G9256 Documentation of patient death following cas
G9257 Documentation of patient stroke following cas
G9258 Documentation of patient stroke following cea
G9259 Documentation of patient survival and absence of stroke following cas
G9260 Documentation of patient death following cea
G9261 Documentation of patient survival and absence of stroke following cea
G9262 Documentation of patient death in the hospital following endovascular aaa repair
G9263 Documentation of patient survival in the hospital following endovascular aaa repair
G9264 Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (eg, patient is undergoing palliative dialysis with a catheter, patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant, other medical reasons, patient declined avf/avg, other patient reasons)
G9265 Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access
G9266 Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access
G9267 Documentation of patient with one or more complications or mortality within 30 days
G9268 Documentation of patient with one or more complications within 90 days
G9269 Documentation of patient without one or more complications and without mortality within 30 days
G9270 Documentation of patient without one or more complications within 90 days
G9273 Blood pressure has a systolic value of < 140 and a diastolic value of < 90
G9274 Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90
G9275 Documentation that patient is a current non-tobacco user
G9276 Documentation that patient is a current tobacco user
G9277 Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication to aspirin/anti-platelet. automatic contraindications include anti-coagulant use, allergy, and history of gastrointestinal bleed. additionally, any reason documented by the physician as a reason for not taking daily aspirin or anti-platelet is acceptable (examples include non-steroidal anti-inflammatory agents, risk for drug interaction, or uncontrolled hypertension defined as > 180 systolic or > 110 diastolic
G9278 Documentation that the patient is not on daily aspirin or anti-platelet regimen
G9279 Pneumococcal screening performed and documentation of vaccination received prior to discharge
G9280 Pneumococcal vaccination not administered prior to discharge, reason not specified
G9281 Screening performed and documentation that vaccination not indicated/patient refusal
G9282 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons)
G9283 Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9284 Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9285 Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer
G9286 Documentation of antibiotic regimen prescribed within 7 days of diagnosis or within 10 days after onset of symptoms
G9287 No antibiotic regimen prescribed within 7 days of diagnosis or within 10 days after onset of symptoms
G9288 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons )
G9289 Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9290 Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9291 Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos
G9292 Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)
G9293 Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
G9294 Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
G9295 Specimen site other than anatomic cutaneous location
G9296 Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure
G9297 Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given
G9298 Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)
G9299 Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)
G9300 Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)
G9301 Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet
G9302 Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given
G9303 Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given
G9304 Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant
G9305 Intervention for presence of leak of endoluminal contents through an anastomosis not required
G9306 Intervention for presence of leak of endoluminal contents through an anastomosis required
G9307 No return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure
G9308 Unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure
G9309 No unplanned hospital readmission within 30 days of principal procedure
G9310 Unplanned hospital readmission within 30 days of principal procedure
G9311 No surgical site infection
G9312 Surgical site infection
G9313 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason (eg, cystic fibrosis, immotile cilia disorders, ciliary dyskinesia, immune deficiency, prior history of sinus surgery within the past 12 months, and anatomic abnormalities, such as deviated nasal septum, resistant organisms, allergy to medication, recurrent sinusitis, chronic sinusitis, or other reasons)
G9314 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given
G9315 Documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis
G9316 Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family
G9317 Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed
G9318 Imaging study named according to standardized nomenclature
G9319 Imaging study not named according to standardized nomenclature, reason not given
G9320 Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9321 Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study
G9322 Count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given
G9323 Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9324 All necessary data elements not included, reason not given
G9325 Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9326 Ct studies performed not reported to a radiation dose index registry, reason not given
G9327 Ct studies performed reported to a radiation dose index registry with all necessary data elements
G9328 Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9329 Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not given
G9340 Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study
G9341 Search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed
G9342 Search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive, reason not given
G9343 Due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external heatlhcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9344 Due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., non-affiliated external healthcare facilities or entities does not have archival abilities through a shared archival system)
G9345 Follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors
G9346 Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9347 Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given
G9348 Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons (eg, persons with sinusitis symptoms lasting at least 7 to 10 days, antibiotic resistance, immunocompromised, recurrent sinusitis, acute frontal sinusitis, acute sphenoid sinusitis, periorbital cellulitis, or other medical)
G9349 Documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis
G9350 Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis
G9351 More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis
G9352 More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given
G9353 More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)
G9354 More than one ct scan of the paranasal sinuses not ordered within 90 days after the date of diagnosis
G9355 Elective delivery or early induction not performed
G9356 Elective delivery or early induction performed
G9357 Post-partum screenings, evaluations and education performed
G9358 Post-partum screenings, evaluations and education not performed
G9359 Documentation of negative or managed positive tb screen with further evidence that tb is not active
G9360 No documentation of negative or managed positive tb screen
G9362 Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer, as documented in the anesthesia record
G9363 Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record
G9364 Sinusitis caused by, or presumed to be caused by, bacterial infection
G9365 One high-risk medication ordered
G9366 One high-risk medication not ordered
G9367 At least two different high-risk medications ordered
G9368 At least two different high-risk medications not ordered
G9369 Individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greater
G9370 Individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greater
G9376 Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery
G9377 Patient did not have the retina attached after 6 months following only one surgery
G9378 Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month)
G9379 Patient did not achieve flat retinas six months post surgery
G9380 Patient offered assistance with end of life issues during the measurement period
G9381 Documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period
G9382 Patient not offered assistance with end of life issues during the measurement period
G9383 Patient received screening for hcv infection within the 12 month reporting period
G9384 Documentation of medical reason(s) for not receiving screening for hcv infection within the 12 month reporting period (e.g., decompensated cirrhosis including advanced disease [ie, ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, or waitlist for organ transplant, limited life expectancy, other medical reasons)
G9385 Documentation of patient reason(s) for not receiving screening for hcv infection within the 12 month reporting period (e.g., patient declined, other patient reasons)
G9386 Screening for hcv infection not received within the 12 month reporting period, reason not given
G9389 Unplanned rupture of the posterior capsule requiring vitrectomy
G9390 No unplanned rupture of the posterior capsule requiring vitrectomy
G9391 Patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit
G9392 Patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit
G9393 Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five
G9394 Patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period
G9395 Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five
G9396 Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)
G9399 Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward the outcome of the treatment
G9400 Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasons
G9401 No documentation of a discussion in the patient record of a discussion between the physician or other qualfied healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment
G9402 Patient received follow-up on the date of discharge or within 30 days after discharge
G9403 Clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)
G9404 Patient did not receive follow-up on the date of discharge or within 30 days after discharge
G9405 Patient received follow-up within 7 days from discharge
G9406 Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)
G9407 Patient did not receive follow-up on or within 7 days after discharge
G9408 Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days
G9409 Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days
G9410 Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
G9411 Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
G9412 Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
G9413 Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
G9414 Patient had one dose of meningococcal vaccine on or between the patient''s 11th and 13th birthdays
G9415 Patient did not have one dose of meningococcal vaccine on or between the patient''s 11th and 13th birthdays
G9416 Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) or one tetanus, diphtheria toxoids vaccine (td) on or between the patient''s 10th and 13th birthdays or one tetanus and one diptheria vaccine on or between the patient''s 10th and 13th birthdays
G9417 Patient did not have one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) or one tetanus, diphtheria toxoids vaccine (td) on or between the patient''s 10th and 13th birthdays or one tetanus and one diptheria vaccine on or between the patient''s 10th and 13th birthdays
G9418 Primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9419 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of primary non-small cell lung cancer or other documented medical reasons)
G9420 Specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer
G9421 Primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9422 Non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9423 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)
G9424 Specimen site other than anatomic location of lung, is not classified as non-small cell lung cancer or classified as nsclc-nos
G9425 Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9426 Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients
G9427 Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients
G9428 Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
G9429 Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)
G9430 Specimen site other than anatomic cutaneous location
G9431 Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
G9432 Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented
G9433 Death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period
G9434 Asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given
G9435 Aspirin prescribed at discharge
G9436 Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)
G9437 Aspirin not prescribed at discharge
G9438 P2y inhibitor prescribed at discharge
G9439 P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)
G9440 P2y inhibitor not prescribed at discharge
G9441 Statin prescribed at discharge
G9442 Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)
G9443 Statin not prescribed at discharge
G9448 Patients who were born in the years 1945?1965
G9449 History of receiving blood transfusions prior to 1992
G9450 History of injection drug use
G9451 Patient received one-time screening for hcv infection
G9452 Documentation of medical reason(s) for not receiving one-time screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [ie, ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)
G9453 Documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)
G9454 One-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given
G9455 Patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc
G9456 Documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival < 5 years, hepatic decompensation and not a candidate for liver transplantation, or other medical reasons; patient reasons: patient declined or other patient reasons (e.g., cost of tests, time related to accessing testing equipment)
G9457 Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period
G9458 Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user
G9459 Currently a tobacco non-user
G9460 Tobacco assessment or tobacco cessation intervention not performed, reason not otherwise specified
G9463 I intend to report the sinusitis measures group
G9464 All quality actions for the applicable measures in the sinusitis measures group have been performed for this patient
G9465 I intend to report the acute otitis externa (aoe) measures group
G9466 All quality actions for the applicable measures in the aoe measures group have been performed for this patient
G9467 Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills
G9468 Patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills
G9469 Patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills
G9470 Patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills
G9471 Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented
G9472 Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed